Infection by Enteropathogenic Escherichia coli (ICD-11: 1A03.0)

1. Introduction

Infection by enteropathogenic Escherichia coli (EPEC) represents one of the leading causes of persistent diarrhea in infants and young children, especially in regions with limited resources and poor sanitary conditions. This condition, coded as 1A03.0 in the ICD-11 system, is distinguished by its ability to cause prolonged diarrhea that persists for two weeks or more, differentiating itself from other pathogenic strains of E. coli by its specific virulence mechanisms.

EPEC was historically recognized as the first pathotype of diarrheagenic E. coli identified, being responsible for significant outbreaks in nurseries and daycare centers during the 1940s and 1950s. Although its prevalence has decreased in developed countries with better sanitation conditions, it continues to be a substantial threat to child health in developing countries, where it represents an important cause of pediatric morbidity and mortality.

Transmission occurs primarily through the fecal-oral route, with contaminated water, inadequately prepared food, and direct contact with infected animals serving as the main vehicles of dissemination. The capacity of this bacterium to cause characteristic lesions in intestinal epithelial cells, known as attaching and effacing lesions, results in persistent malabsorption and prolonged watery diarrhea that can lead to malnutrition and impaired child growth.

Precise coding of this condition is critical for epidemiological monitoring, adequate allocation of public health resources, implementation of targeted preventive strategies, and research on antimicrobial resistance. Correct recognition of EPEC allows for appropriate therapeutic interventions and infection control measures that can prevent outbreaks in institutional settings.

2. Correct ICD-11 Code

Code: 1A03.0

Description: Infection by enteropathogenic Escherichia coli

Parent category: 1A03 - Intestinal infections by Escherichia coli

Official definition: Persistent diarrhea lasting 2 weeks or more, secondary to infection by enteropathogenic strains of E. coli, which spreads among humans through contact with contaminated water and/or infected animals, typically in developing countries.

The code 1A03.0 is positioned within the hierarchical structure of ICD-11 as a specific subcategory of intestinal infections caused by E. coli. This classification reflects the need to clearly distinguish between different pathotypes of diarrheagenic E. coli, each with distinct clinical, epidemiological, and pathogenic characteristics.

EPEC is classified into two main subgroups: typical EPEC (tEPEC), which possesses the EAF virulence plasmid (EPEC adherence factor), and atypical EPEC (aEPEC), which lacks this plasmid but maintains the capacity to produce adherence and effacement lesions. Both subgroups are included under code 1A03.0, although they present differences in virulence and epidemiology.

Appropriate coding requires laboratory confirmation of the presence of enteropathogenic strains through microbiological or molecular methods, together with compatible clinical manifestations, especially the presence of persistent diarrhea lasting a minimum of two weeks. This temporal criterion is fundamental to differentiate EPEC from other causes of self-limited acute gastroenteritis.

3. When to Use This Code

Code 1A03.0 should be applied in specific clinical scenarios where there is confirmation or strong suspicion of infection by enteropathogenic E. coli:

Scenario 1: Infant with persistent diarrhea in institutional setting An 8-month-old child admitted to daycare develops profuse watery diarrhea that persists for three weeks. Stool culture identifies E. coli with characteristic genetic markers of EPEC (eae and bfp genes). The child presents with moderate dehydration and significant weight loss. This is the classic scenario for use of code 1A03.0, especially when similar cases are identified in the same institution.

Scenario 2: Child with prolonged diarrhea after travel A 2-year-old pediatric patient develops abundant watery diarrhea during travel to a region with poor sanitary conditions. Symptoms persist for 18 days after return, with multiple daily bowel movements without visible blood. Laboratory tests confirm presence of EPEC through specific PCR. The absence of high fever and blood in stool, combined with prolonged duration, justifies code 1A03.0.

Scenario 3: Outbreak in hospital nursery Multiple neonates in special care unit develop watery diarrhea simultaneously. Epidemiological investigation identifies enteropathogenic E. coli as the common etiological agent through molecular typing. Cases present with persistent diarrhea for more than 14 days, with progressive nutritional compromise. Each case should be coded as 1A03.0, with additional documentation regarding the outbreak context.

Scenario 4: Chronic diarrhea with documented malabsorption 6-month-old infant with history of watery diarrhea for 4 weeks, presenting with steatorrhea and signs of malabsorption. Upper gastrointestinal endoscopy shows nonspecific villous changes. Stool culture with specific typing identifies typical EPEC. Persistence of symptoms beyond two weeks, combined with evidence of malabsorption and laboratory confirmation, supports use of code 1A03.0.

Scenario 5: Child with malnutrition and persistent diarrhea 18-month-old pediatric patient presenting with progressive malnutrition associated with continuous watery diarrhea for 3 weeks. Etiological investigation through molecular methods identifies E. coli with virulence genes characteristic of EPEC (eae positive, stx negative, lt/st negative). Exclusion of other enteric pathogens and specific confirmation of EPEC justify code 1A03.0.

Scenario 6: Persistent infection in immunocompromised patient Child with primary immunodeficiency develops prolonged watery diarrhea for more than one month. Multiple stool cultures isolate enteropathogenic E. coli. The unusual persistence of symptoms in immunocompromised patient, with repeated microbiological confirmation, indicates appropriate use of code 1A03.0, possibly with additional codes to document the underlying immunological condition.

4. When NOT to Use This Code

It is fundamental to recognize situations where code 1A03.0 is not appropriate, avoiding coding errors that may compromise epidemiological data and clinical management:

Self-limited acute diarrhea: When diarrhea caused by E. coli has a duration of less than two weeks and resolves spontaneously, even if EPEC is isolated, code 1A03.0 should not be applied. The specific definition requires persistence for 14 days or more.

Other diarrheagenic E. coli strains: The identification of enterotoxigenic E. coli (ETEC), enteroinvasive (EIEC), enterohemorrhagic (EHEC), enteroaggregative (EAEC), or diffusely adherent (DAEC) requires different specific codes. Each pathotype has distinct virulence mechanisms, clinical presentations, and ICD-11 codes.

Bloody diarrhea and high fever: When the clinical presentation includes frank dysentery (bloody diarrhea) with elevated fever, it is more likely to be EIEC (code 1A03.2) or Shigella, not EPEC. EPEC typically causes watery diarrhea without visible blood.

Hemolytic-uremic syndrome: Patients who develop microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure following bloody diarrhea likely have infection with Shiga toxin-producing E. coli (STEC/EHEC), coded as 1A03.3, not EPEC.

Traveler's diarrhea of short duration: Classic traveler's diarrhea lasting 3-5 days is more frequently caused by ETEC (code 1A03.1) and should not be coded as 1A03.0, even if it occurs in regions endemic for EPEC.

Absence of adequate confirmation: When there is no laboratory confirmation of EPEC and the clinical presentation is nonspecific, more general gastroenteritis codes should be considered until definitive investigation is performed.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

Correct coding begins with adequate diagnostic confirmation. The diagnosis of EPEC infection requires both clinical and laboratory criteria:

Essential clinical criteria:

Watery diarrhea lasting 14 days or more
Typical absence of visible blood in stool
Absent or low-grade fever (different from invasive infections)
Signs of dehydration variable according to severity
Evidence of malabsorption in prolonged cases

Laboratory confirmation: Definitive confirmation requires isolation of E. coli with specific EPEC characteristics through:

Stool culture with identification of E. coli
PCR testing for virulence genes (eae, bfp)
Serotyping to identify typical EPEC serogroups
Exclusion of genes for Shiga toxins (stx), enterotoxins (lt, st) and invasion (ipaH)

Necessary complementary evaluations:

Complete blood count to assess anemia and leukocytosis
Serum electrolytes to assess hydroelectrolytic disturbances
Assessment of nutritional status and growth
Parasitological examination of stool to exclude coinfections

Step 2: Check Specifiers

After confirming the diagnosis, evaluate specific characteristics that may influence coding:

Duration of illness: Document precisely how long symptoms have been present. The minimum duration of 14 days is a mandatory criterion, but many cases persist for several weeks or months.

Clinical severity: Classify severity based on:

Number of daily bowel movements
Degree of dehydration (mild, moderate, severe)
Nutritional impact and weight loss
Need for hospitalization
Associated complications

EPEC subtype: When possible, identify whether it is typical EPEC (with EAF plasmid) or atypical EPEC (without EAF plasmid), although both are coded as 1A03.0. This distinction may be relevant for prognosis and epidemiological research.

Epidemiological context: Document whether the case is sporadic or part of an outbreak, if there is a history of travel, exposure to contaminated water, or contact with similar cases.

Step 3: Differentiate from Other Codes

1A03.1: Infection by enterotoxigenic Escherichia coli (ETEC)

Key difference: ETEC causes acute watery self-limited diarrhea (usually 3-5 days), not persistent. Produces heat-labile (LT) and/or heat-stable (ST) enterotoxins. It is the most common cause of traveler's diarrhea. Does not produce adherence and effacement lesions.

1A03.2: Infection by enteroinvasive Escherichia coli (EIEC)

Key difference: EIEC causes dysentery with fever, bloody diarrhea and cramping abdominal pain, similar to shigellosis. Invades intestinal epithelial cells through a mechanism different from EPEC. Clinical presentation is acute, not persistent.

1A03.3: Infection by enterohemorrhagic Escherichia coli (EHEC)

Key difference: EHEC produces Shiga toxins (Stx1 and/or Stx2) causing hemorrhagic colitis with diarrhea initially watery that progresses to bloody. May be complicated by hemolytic-uremic syndrome. The O157:H7 serotype is the most well-known, but others exist.

1A03.4: Infection by enteroaggregative Escherichia coli (EAEC)

Key difference: EAEC causes persistent diarrhea through an aggregative adherence pattern. Although it also causes prolonged diarrhea, especially in children and immunocompromised individuals, it has distinct genetic markers (aggR, aatA genes).

Step 4: Necessary Documentation

Checklist of mandatory information in the medical record:

□ Date of symptom onset and documented duration □ Characteristics of bowel movements (frequency, consistency, presence of blood/mucus) □ Stool culture results with E. coli identification □ Results of molecular or serological tests confirming EPEC □ Exclusion of other enteric pathogens □ Assessment of hydration status □ Nutritional impact and body weight □ Treatment instituted and therapeutic response □ Epidemiological context (travel, outbreak, exposure) □ Complications if present

How to document properly: Documentation should include detailed clinical narrative describing the temporal evolution of symptoms, specific laboratory results with dates, interventions performed, and justification for code 1A03.0. In outbreak cases, reference the corresponding epidemiological investigation.

6. Complete Practical Example

Clinical Case

Initial presentation: A 10-month-old female patient is brought to the consultation with a history of watery diarrhea for 18 days. The mother reports that the child has 6-8 daily bowel movements of liquid consistency, without visible blood, associated with occasional vomiting. The child has been attending daycare for 3 months. Over the past two weeks, the mother noticed that the child is more irritable, with decreased appetite and estimated weight loss of 500 grams.

Evaluation performed: On physical examination, the child appears active but irritable, with signs of mild dehydration (slightly dry mucous membranes, slightly diminished skin turgor). Current weight: 7.8 kg (previous documented weight 1 month ago: 8.3 kg). Axillary temperature: 37.2°C. Abdomen slightly distended, increased bowel sounds, without masses or organomegaly.

Laboratory tests ordered:

Complete blood count: leukocytes 9,800/mm³ (normal), without shift
Electrolytes: sodium 136 mEq/L, potassium 3.4 mEq/L (mild hypokalemia)
Parasitological stool examination: negative for parasites
Stool culture: E. coli growth
PCR for virulence genes: eae positive, bfp positive, stx negative, lt/st negative
Testing for other pathogens (Salmonella, Shigella, Campylobacter): negative

Diagnostic reasoning: The combination of persistent watery diarrhea for more than 14 days, absence of significant fever or blood in stool, documented weight loss, and laboratory confirmation of E. coli with genetic markers characteristic of typical EPEC (eae and bfp positive, with exclusion of other virulence genes) establishes the diagnosis of infection by enteropathogenic E. coli.

Additional investigation revealed that three other similar cases occurred at the same daycare in the past month, suggesting transmission in an institutional setting. The patient's age (infant), the epidemiological context, and the prolonged duration of symptoms are all consistent with the typical profile of EPEC infection.

Coding justification: This case meets all criteria for code 1A03.0:

Persistent diarrhea lasting longer than 14 days (18 days)
Laboratory confirmation of typical EPEC through molecular methods
Exclusion of other diarrheagenic E. coli pathotypes
Compatible clinical presentation (watery diarrhea, without blood)
Appropriate epidemiological context (transmission in daycare)

Step-by-Step Coding

Criteria analysis:

✓ Duration ≥ 14 days: YES (18 days)
✓ EPEC confirmation: YES (PCR positive for eae and bfp)
✓ Exclusion of other pathogens: YES (negative tests)
✓ Compatible clinical characteristics: YES (persistent watery diarrhea)
✓ Adequate documentation: YES (evolution and tests recorded)

Code selected: 1A03.0 - Infection by enteropathogenic Escherichia coli

Complete justification: Code 1A03.0 is appropriate because the patient presents with clinical and laboratory findings characteristic of typical EPEC infection, with persistent diarrhea documented for 18 days, molecular confirmation of the presence of specific EPEC virulence genes (eae and bfp), exclusion of other pathotypes through negative tests for Shiga toxins, enterotoxins and invasion markers, and epidemiological context consistent with transmission in an institutional setting.

Applicable complementary codes:

5C72.0 - Dehydration (to document complication present)
5B51 - Protein-energy malnutrition (if nutritional evaluation confirms)
Z code for history of exposure in institutional setting, if applicable in the local system

7. Related Codes and Differentiation

Within the Same Category

1A03.1: Infection by enterotoxigenic Escherichia coli (ETEC)

When to use vs. 1A03.0: Use 1A03.1 when there is confirmation of heat-labile (LT) and/or heat-stable (ST) enterotoxin production through specific tests. The typical clinical presentation is self-limited acute watery diarrhea lasting 3-5 days, not persistent as in EPEC.

Main difference: ETEC causes acute (non-persistent) diarrhea, is the leading cause of traveler's diarrhea, and the pathogenic mechanism involves enterotoxin production that alters electrolyte transport without causing structural lesions in the intestinal epithelium. EPEC causes persistent diarrhea (≥14 days) through adhesion and effacement lesions in the epithelium.

1A03.2: Infection by enteroinvasive Escherichia coli (EIEC)

When to use vs. 1A03.0: Use 1A03.2 when the clinical presentation includes dysentery (diarrhea with blood and mucus), high fever, and intense cramping abdominal pain. Laboratory confirmation shows E. coli with invasive capacity (ipaH gene positive).

Main difference: EIEC invades epithelial cells of the colon causing acute inflammation with tissue destruction, resulting in dysentery similar to shigellosis. The presentation is acute and febrile, not persistent and watery as in EPEC. The presence of blood and mucus in stool is characteristic of EIEC, not EPEC.

1A03.3: Infection by enterohemorrhagic Escherichia coli (EHEC)

When to use vs. 1A03.0: Use 1A03.3 when there is confirmation of Shiga toxin (Stx1 and/or Stx2) production through specific tests. Typical presentation is hemorrhagic colitis with diarrhea initially watery evolving to abundant bloody diarrhea, with risk of hemolytic-uremic syndrome.

Main difference: EHEC produces Shiga toxins that cause vascular damage and may lead to severe systemic complications (hemolytic-uremic syndrome, thrombotic thrombocytopenic purpura). Diarrhea evolves from watery to frankly bloody. EPEC does not produce Shiga toxins and rarely causes bloody diarrhea.

1A03.Y: Other specified intestinal infections by Escherichia coli

This code is used for less common pathotypes such as enteroaggregative E. coli (EAEC) and diffusely adherent E. coli (DAEC), which have virulence mechanisms and adhesion patterns distinct from EPEC.

Differential Diagnoses

Rotavirus Infections: Although it also causes watery diarrhea in infants, rotavirus infection is typically self-limited (5-7 days) and frequently accompanied by prominent vomiting and fever. Duration rarely exceeds two weeks in immunocompetent individuals.

Giardiasis: Can cause persistent diarrhea with malabsorption, but stool parasitological examination identifies cysts or trophozoites of Giardia lamblia. Diarrhea tends to be fatty (steatorrhea) and with prominent abdominal distension.

Celiac Disease: Causes chronic diarrhea with malabsorption, but there is no fever or epidemiological context of an outbreak. Celiac serology (anti-transglutaminase) is positive and duodenal biopsy shows characteristic villous atrophy.

Secondary Lactose Intolerance: Can occur after acute gastroenteritis, causing persistent diarrhea that improves with lactose withdrawal from the diet. There is no pathogen identified in stool cultures.

8. Differences with ICD-10

Equivalent ICD-10 code: A04.0 - Infection due to enteropathogenic Escherichia coli

Main changes in ICD-11:

The transition from ICD-10 to ICD-11 brought significant refinements in the coding of E. coli infections:

Enhanced hierarchical structure: In ICD-11, code 1A03.0 is clearly positioned within category 1A03 (Intestinal infections due to Escherichia coli), which groups all pathotypes of diarrheagenic E. coli in a more logical and organized manner. ICD-10 had a less systematized structure.

Increased specificity: ICD-11 provides distinct codes for each major pathotype of diarrheagenic E. coli (1A03.0 for EPEC, 1A03.1 for ETEC, 1A03.2 for EIEC, 1A03.3 for EHEC), whereas ICD-10 had less clear differentiation between some pathotypes.

More precise definitions: ICD-11 includes more detailed definitions that specify clinical criteria (duration ≥14 days for EPEC) and epidemiological factors, facilitating consistent coding across different coders and institutions.

Digital compatibility: The ICD-11 structure was developed considering electronic health systems, with better integration to clinical terminologies and ability to link with other classification systems.

Practical impact of these changes:

For healthcare professionals, ICD-11 offers greater clarity in differentiating between E. coli pathotypes, reducing ambiguity in coding. Epidemiological surveillance systems benefit from more precise data on the distribution of different pathotypes. The transition requires coder training for familiarization with the new numerical structure and specific criteria, but results in more accurate documentation useful for research and public health.

9. Frequently Asked Questions

1. How is a definitive diagnosis of EPEC infection made?

Definitive diagnosis requires a combination of clinical and laboratory criteria. Clinically, there must be persistent watery diarrhea for 14 days or more, typically in infants or young children. Laboratorially, it is necessary to isolate E. coli from stool and confirm that it is an enteropathogenic strain through molecular tests (PCR for eae and bfp genes) or serological tests (identification of typical EPEC serogroups). Exclusion of other enteric pathogens through culture and specific tests strengthens the diagnosis. In resource-limited settings where molecular tests are not available, identification of classic EPEC serogroups by serotyping can be used, although it is less specific.

2. Is treatment available in public health systems?

Yes, treatment of EPEC infection is generally available in public health systems, although the approach is primarily supportive. Fundamental management consists of oral or intravenous rehydration as needed, maintenance of adequate nutrition, and nutritional support when indicated. Antibiotics may be considered in severe or persistent cases, but are not routinely recommended due to concerns about antimicrobial resistance and limited efficacy. Antidiarrheal medications are not recommended in young children. Oral rehydration solutions are widely available and constitute the basis of treatment. In cases with associated malnutrition, nutritional supplementation and specialized follow-up may be necessary.

3. How long does treatment and recovery last?

The duration of treatment and recovery varies considerably among patients. By definition, diarrhea persists for at least 14 days, but may extend for several weeks or even months in untreated cases or in malnourished children. With adequate treatment, including appropriate rehydration and nutritional support, most children show gradual improvement in 2-4 weeks. Complete nutritional recovery, especially in cases with associated malnutrition, may take several months. Factors that influence duration include the child's age (young infants tend to have more prolonged disease), previous nutritional status, access to adequate treatment, and presence of coinfections. Follow-up should continue until complete normalization of bowel pattern and recovery of weight and growth.

4. Can this code be used in medical certificates and official documents?

Yes, code 1A03.0 can and should be used in medical certificates, hospital reports, discharge documents, and other official records when appropriate. Accurate coding is important for proper documentation of the condition, justification of school or occupational absences (in the case of caregivers), and for epidemiological surveillance purposes. In certificates, it is common to include both the ICD code and a description in accessible language (for example, "persistent intestinal infection"). For purposes of school exclusion of children in daycare or schools, proper documentation is particularly important due to the potential for transmission in institutional settings. Public health authorities may require case notification, especially in outbreak contexts.

5. Is there a vaccine available against EPEC?

Currently, there is no licensed vaccine specifically against enteropathogenic E. coli. Vaccine development against EPEC faces challenges due to the diversity of serogroups and virulence mechanisms. Research is underway to develop multivalent vaccines that could protect against multiple pathotypes of diarrheagenic E. coli, including EPEC, but there are no products available for clinical use yet. Prevention currently relies on public health measures: access to safe drinking water, adequate sanitation, hand hygiene, safe food preparation, exclusive breastfeeding in the first 6 months of life (which provides partial protection), and infection control measures in institutional settings such as daycare centers and hospitals.

6. What is the difference between typical and atypical EPEC, and does this affect coding?

Typical EPEC (tEPEC) possesses the EAF plasmid (EPEC adherence factor) that encodes the bundle-forming pilus (BFP) fimbria, while atypical EPEC (aEPEC) lacks this plasmid but maintains the LEE pathogenicity island (locus of enterocyte effacement) that encodes the eae gene. Both cause adherence and effacement lesions, but tEPEC generally has greater virulence and is more frequently associated with outbreaks in developing countries, while aEPEC has broader distribution and may affect both children and adults. For ICD-11 coding purposes, both subtypes are classified under the same code 1A03.0, as they share similar clinical manifestations (persistent diarrhea) and fundamental pathogenic mechanism (attaching and effacing lesions). The distinction between typical and atypical is relevant for epidemiological and microbiological research, but does not alter clinical coding.

7. Can children with EPEC infection attend daycare during treatment?

No, children with active EPEC infection should not attend daycare or school until complete resolution of symptoms and, ideally, confirmation of pathogen clearance. EPEC is highly transmissible in institutional settings through the fecal-oral route, especially among infants and young children with developing hygiene habits. Outbreaks in daycare centers are well documented and can be difficult to control. General recommendations include exclusion for at least 24-48 hours after the last episode of diarrhea, although some public health protocols may require stricter criteria, including negative stool cultures. Return should be authorized by a healthcare professional, and the institution should be notified to implement infection control measures, including rigorous hand hygiene, surface disinfection, and monitoring for new cases.

8. Can EPEC infection cause long-term complications?

Yes, EPEC infection can result in significant complications, especially when not treated adequately. The most important complication is secondary malnutrition due to prolonged diarrhea and malabsorption, which can compromise child growth and development. Studies demonstrate an association between repeated episodes of persistent EPEC diarrhea and linear growth deficit (stunting) in children from developing countries. Prolonged malabsorption can cause micronutrient deficiencies, particularly zinc and vitamin A. In some cases, secondary lactose intolerance may develop and persist for weeks after resolution of infection. Rarely, post-infectious syndrome may occur with persistent alterations in intestinal motility. Prevention of these complications requires early diagnosis, adequate treatment with emphasis on nutritional support, and follow-up to ensure complete recovery of growth and development.

Conclusion:

Proper coding of enteropathogenic Escherichia coli infection using ICD-11 code 1A03.0 requires clear understanding of diagnostic criteria, especially diarrhea persistence for 14 days or more and laboratory confirmation of enteropathogenic strains. Precise differentiation from other diarrheagenic E. coli pathotypes is fundamental for correct coding, appropriate clinical management, and effective epidemiological surveillance. Recognition of this condition and its proper documentation are essential for implementation of public health measures that can prevent outbreaks in institutional settings and improve outcomes in vulnerable populations, particularly infants and young children in resource-limited regions.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-04

Infection by Enteropathogenic Escherichia coli

Compartilhar